Erlmeier, F.* ; Sun, N. ; Shen, J. ; Feuchtinger, A. ; Buck, A. ; Prade, V.M. ; Kunzke, T. ; Schraml, P.* ; Moch, H.* ; Autenrieth, M.* ; Weichert, W.* ; Hartmann, A.* ; Walch, A.K.
MALDI mass spectrometry imaging-Diagnostic pathways and metabolites for renal tumor entities.
Oncology 101, 126-133 (2022)
Boeck, S.* ; Wilkowski, R.* ; Bruns, C.J.* ; Issels, R.D. ; Schulz, C.* ; Moosmann, N.* ; Laessig, D.* ; Haas, M.* ; Golf, A.* ; Heinemann, V.*
Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer.
Oncology 73, 221-227 (2007)
Schlemmer, M.* ; Wendtner, C.M.* ; Falk, M.* ; Abdel-Rahman, S.* ; Licht, T.* ; Baumert, J.J. ; Straka, C.* ; Hentrich, M.* ; Salat, C.* ; Hiddemann, W.* ; Issels, R.D.
Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas.
Oncology 71, 32-39 (2006)
Mergenthaler, H.G. ; Binsack, T. ; Wilmanns, W.
Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy.
Oncology 45, 11-14 (1988)